Related Experiment Video
Updated: Oct 2, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer
Jieyun Sun1,2, Xintian Chen3, Xueying Ji2
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
Tripartite motif-containing 21 (TRIM21) has been reported to have a cancer-promoting or anticancer effect in various tumors; however, its role in ovarian cancer (OC) remains to be elucidated. In this study, we explored the biological function of TRIM21 in OC progression and investigated the potential mechanisms. We found that TRIM21 was remarkably decreased in OC tissues and cell lines compared with adjacent-cancerous tissues and normal ovarian epithelium cell. Decreased expression of TRIM21 in OC patients was significantly correlated with shorter overall and disease-specific survival by The Cancer Genome Atlas database (TCGA) analysis. Functional assays revealed that TRIM21 inhibited the migration and invasion of OC cells; and that TRIM21 also obviously impaired cell proliferation by inhibiting cell cycle progression in vitro and in vivo. Taken together, our results suggest that TRIM21 may be a promising biomarker and target for OC diagnosis and treatment.
Insights
Tripartite motif-containing 21 (TRIM21) is decreased in ovarian cancer (OC), hindering cell proliferation and invasion. This suggests TRIM21 could be a potential biomarker and therapeutic target for OC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The role of Tripartite motif-containing 21 (TRIM21) in cancer is context-dependent, with its function in ovarian cancer (OC) not yet fully understood.
- Understanding TRIM21's specific role in OC is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the biological function of TRIM21 in ovarian cancer progression.
- To elucidate the underlying mechanisms of TRIM21's action in OC.
- To assess TRIM21 as a potential diagnostic and therapeutic target for OC.
Main Methods:
- Analysis of TRIM21 expression in OC tissues and cell lines.
- Utilized The Cancer Genome Atlas (TCGA) database for survival analysis.
- Performed in vitro and in vivo functional assays to assess proliferation, migration, and invasion.
Main Results:
- TRIM21 expression was significantly downregulated in OC tissues and cell lines compared to normal controls.
- Lower TRIM21 levels correlated with reduced overall and disease-specific survival in OC patients.
- TRIM21 suppressed OC cell proliferation, migration, and invasion by inhibiting cell cycle progression.
Conclusions:
- TRIM21 acts as a tumor suppressor in ovarian cancer.
- Decreased TRIM21 expression is linked to poor prognosis in OC.
- TRIM21 represents a promising biomarker and therapeutic target for ovarian cancer diagnosis and treatment.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

